1Kozlowski P, Chang SD, Goldenberg SL. Diffusion-weightedMRI in prostate cancer:comparison between single-shot fastspin echo and echo planar imaging sequences[J].Magn ResonImaging, 2008, 26(1):72-76.
2Porter DA, Heidemann RM. High resolutiondiffusion-weighted imaging using readout-segmentedecho-planar imaging, parallel imaging and a two-dimensionalnavigator-based reacquisition[J].Magn Reson Med, 2009, 62(2):468-475.
3Thian YL, Xie W, Porter DA, et al. Readout-segmentedecho-planar imaging for diffusion-weighted imaging in thepelvis at 3T-A feasibility study[J].Acad Radiol, 2014,21 (4):531-537.
5Saritas EU, Cunningham CH, Lee JH, et al. DWI of thespinal cord with reduced FOV single-shot EPI[J].Magn ResonMed, 2008, 60(2):468-473.
6Thierfelder KM, Sommer WH, Dietrich 0,et al.Parallel-transmit-accelerated spatially-selective excitationMRI for reduced-FOV diffusion-weighted-imaging of thepancreas[J].Eur J Radiol, 2014,83( 10):1709-1714.
7Haider MA, van der Kwast TH, Tanguay J, et al. CombinedT2-weighted and diffusion-weighted MRI for localization ofprostate cancer[J].AJR Am J Roentgenol, 2007, 189 (2):323-328.
8Metens T,Miranda D, Absil J, et al. What is the optimal bvalue in diffusion-weighted MR imaging to depict prostatecancer at 3T[J].Eur Radiol, 2012, 22(3):703-709.
9Sato C, Naganawa S, Nakamura T, et al. Differentiation ofnoncancerous tissue and cancer lesions by apparent diffusioncoefficient values in transition and peripheral zones of theprostate[J].J Magn Reson Imaging, 2005,21(3):258-262.
10Howrey BT,Kuo YF, Lin YL, et al. The impact of PSAscreening on prostate cancer mortality and overdiagnosis ofprostate cancer in the United States[J].J Gerontol A Biol SciMed Sci, 2013,68(1):56-61.
4Beheshti M, Langsteger W, Fogelman I. Prostate cancer: role of SPECT and PET in imaging bone metastases[ J ]. Seminars in nucle- ar medicine ,2009,39:3964-07.
5Zukotynski KA, Kim CK, Gerbaudo VH, et al. 18F-FDG-PET/CT and 18F-NaF-PET/CT in men with castrate-resistant prostate cancer[ J ]. American journal of nuclear medicine and molecular imaging,20150 5:72-82.
6Hricak H, Choyke PL, Eberhardt SC, et al. Imaging prostate canc- er: a muhidisciplinary perspective[ J]. Radiology,2007,243:28-53.
7Ell B, Kang Y. SnapShot: Bone Metastasis [ J ]. Cell, 2012, 151 e690-e691.
8Langsteger W, Haim S, Knaner M, ses in prostate cancer:an update [ J ] et al. Imaging of bone metasta- The quarterly journal of nucle-ar medicine and molecular imaging,2012,56:447-458.
9Morris M J, Akhurst T, Larson SM, et al. Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy[J]. Clin- ical cancer research : an official journal of the American Association for Cancer Research,2005,11:3210-3216.
10Morris M J, Akhurst T, Osman I, et al. Fluorinated deoxyglueose posi- tron emission tomography imaging in progressive metastatic prostate caneer[ J ]. Urology,2002,59:913-918.
